Improving shock risk assessment using blood test markers
Part of Heart & circulation clinical trials.
This study looks at whether adding two simple blood test markers to a standard heart failure score can better predict recovery in people with cardiogenic shock, a condition where the heart cannot pump enough blood. The goal is to help doctors tailor treatment for each patient.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older
- You have cardiogenic shock, meaning your heart is not pumping enough blood, confirmed by low blood pressure and other signs
- Your shock is caused by a heart attack or another heart problem
- You have had a complete blood count test on admission
- Your shock is not caused by infection, dehydration, or a blockage in the lungs
- You do not have active infection, chronic inflammation, blood disorders, cancer, or liver disease
- You have not had a recent blood transfusion and are not on immune-suppressing or steroid treatment
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This registry tracks patients experiencing cardiogenic shock—a serious condition where the heart suddenly cannot pump enough blood to the body. Researchers collect information about patient outcomes and treatments to better understand what helps people recover.
This trial tests whether setting a personalized blood pressure goal for each person in cardiogenic shock improves recovery compared to standard care. It may help if you have severe shock and can be enrolled within the first 24 hours.
This study looks at how people with cardiogenic shock (or very low blood pressure from heart causes) do after treatment in a specialized cardiovascular ICU. It also examines whether care by heart critical-care specialists affects outcomes.
This study looks at whether a person’s genetic information (genomics) can help predict outcomes in cardiogenic shock. You may be asked to give consent and provide information during a serious heart-related emergency, usually soon after symptoms start.
This study tracks how well people with cardiogenic shock (a life-threatening drop in blood flow after a heart attack or heart failure worsening) do when treated with modern support devices and medicines.
This registry collects information from patients admitted to the hospital with cardiogenic shock—a serious condition where the heart cannot pump enough blood to the body. Doctors will gather data to better understand what happens to these patients and how to improve their care.
Hear when a new Cardiogenic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.